uniQure QURE
NASDAQ QURE
$44.50 -0.36 (-0.80%)
As of: Sep 4, 2026 · 3:59 PM EDT

uniQure (QURE) Depreciation & Amortization (CF) (2016 - 2026)

uniQure (QURE) posted quarterly Depreciation & Amortization (CF) of $4.9 million for Q2 2026, up 35.18% year-over-year from $3.6 million in Q2 2025, and up 66.0% quarter-over-quarter from $3.0 million in Q1 2026.

Analysis

uniQure (QURE) Depreciation & Amortization (CF) (2016 - 2026) Analysis & Trends

uniQure's Depreciation & Amortization (CF) history runs 11 years deep, the most recent figure standing at $4.9 million for Q2 2026.

  • In Q2 2026, Depreciation & Amortization (CF) rose 35.18% year-over-year to $4.9 million; the TTM figure through Jun 2026 stood at $14.5 million (down 6.67% YoY), while the FY2025 annual figure was $14.8 million, up 16.76% from the prior year.
  • Depreciation & Amortization (CF) for Q2 2026 stood at $4.9 million, up from $3.0 million in the prior quarter.
  • The five-year high for Depreciation & Amortization (CF) was $4.9 million in Q2 2026, with the low at $2.0 million in Q2 2022.
  • The 5-year median for Depreciation & Amortization (CF) is $2.8 million (2024), against an average of $3.1 million.
  • The sharpest annual moves came in 2023 and 2026: Depreciation & Amortization (CF) surged 79.67% in 2023, then tumbled 34.7% in 2026.
  • uniQure's Depreciation & Amortization (CF) stood at $2.3 million in 2022, then soared by 79.67% to $4.2 million in 2023, then increased by 4.01% to $4.4 million in 2024, then sank by 31.82% to $3.0 million in 2025, then surged by 65.22% to $4.9 million in 2026.
  • Business Quant data shows QURE's Depreciation & Amortization (CF) at $4.9 million in Q2 2026, $3.0 million in Q1 2026, and $3.0 million in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Depreciation & Amortization (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 56.50 Mn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 123.70 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -
5 Revolution Medicines 44.33 Bn 44.33 Bn - -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 40.52 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -
10 uniQure 2.95 Bn 2.95 Bn 5.49 Mn 4.91 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 4.91 Mn
Mar 31, 2026 2.96 Mn
Dec 31, 2025 2.97 Mn
Sep 30, 2025 3.63 Mn
Jun 30, 2025 3.63 Mn
Mar 31, 2025 4.53 Mn
Dec 31, 2024 4.36 Mn
Sep 30, 2024 2.99 Mn
Jun 30, 2024 2.67 Mn
Mar 31, 2024 2.63 Mn
Dec 31, 2023 4.19 Mn
Sep 30, 2023 2.60 Mn
Jun 30, 2023 2.59 Mn
Mar 31, 2023 2.53 Mn
Dec 31, 2022 2.33 Mn
Sep 30, 2022 2.10 Mn
Jun 30, 2022 1.98 Mn
Mar 31, 2022 2.12 Mn
Dec 31, 2021 1.85 Mn
Sep 30, 2021 1.78 Mn